Rocket


Overview
Financials
News + Filings
Key Docs
Charts
Ownership
Insiders





Income Statement
Balance Sheet
Cash Flow Statement

Common Size IS
Op Efficiency
Credit Analysis

Relay Therapeutics, Inc. (RLAY)

Income Statement

Standardized | As Reported Annual | Quarterly | TTM
 
In millions, except per share itemsDec-31-22Dec-31-21Dec-31-20Dec-31-19Dec-31-18
   10-K10-K10-K10-KS-1/A
Revenues  1.43.082.70.00.0
            Revenue growth  -54.4%-96.3%   
Cost of goods sold  0.00.00.00.00.0
Gross profit  1.43.082.70.00.0
            Gross margin  100.0%100.0%100.0%  
Selling, general and administrative   [+]300.7367.7138.584.08.9
Research and development  246.4172.799.970.341.0
Other operating expenses  -246.4-295.7-99.9-154.4 
EBITDA   [+]    -47.7
            EBITDA margin  -21670.9%-7979.5%-67.5%  
Depreciation and amortization      2.2
EBIT   [+]-299.3-241.7-55.80.0-49.9
            EBIT margin  -21670.9%-7979.5%-67.5%  
Non-recurring items   [+] 123.0   
Interest income  8.80.83.48.8 
Other income (expense), net  0.00.00.0-84.11.1
Pre-tax income  -290.5-363.9-52.4-75.3-48.8
Income taxes  0.00.00.00.00.0
            Tax rate  0.0%0.0%0.0%0.0%0.0%
Net income  -290.5-363.9-52.4-75.3-48.8
            Net margin  -21036.1%-12012.9%-63.4%  
   
Basic EPS   [+]($2.59)($3.82)($1.23)($21.82)($19.63)
Diluted EPS   [+]($2.59)($3.82)($1.23)($21.82)($19.63)
   
Shares outstanding (basic)   [+]112.295.142.63.52.5
Shares outstanding (diluted)   [+]112.295.142.63.52.5
   
EBIT is a non-GAAP figure that excludes all non-recurring expenses: restructuring costs, asset impairments, IPR&D writeoffs, and other unusual charges.  

Rocket Data Systems, Inc. © 2019 | Contact Us | Data Disclaimer | Terms of Use | Privacy